Blog

Oct 11, 2024, 17:15

The conundrum of CD8+T cells in low antigenic tumours – Cell Stress and Immunity (CSI) Lab

Cell Stress & Immunity (CSI) Lab shared a post on X:

“Happy to share this nice commentary by Angeliki Datsi (Rüdiger Sorg’s lab) on the conundrum of CD8+T cells in low antigenic tumours e.g., Glioblastoma & its impact on Cancer Immunotherapy!

Read here.”

The conundrum of CD8+T cells in low antigenic tumours - Cell Stress and Immunity (CSI) Lab

The conundrum of CD8⁺ T cell trajectories in low antigenic tumors: How to overcome a hypofunctional state distinct from antigen-driven exhaustion?

Authors: Angeliki Datsi, Rüdiger V. Sorg and Abhishek D. Garg.

The conundrum of CD8+T cells in low antigenic tumours - Cell Stress and Immunity (CSI) Lab

Abhishek D. Garg Angeliki Datsi antigenic tumours cancer cancer awareness cancer care cancer immunotherapy Cell Stress & Immunity (CSI) Lab Cell Stress and Immunity csi csi lab fight against cancer glioblastoma Global fight against cancer OncoDaily Oncology Rüdiger Sorg's lab Rüdiger V. Sorg

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage